Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate.

Client Email

Product

4-(diethylamino)but-2-yn-1-yl Cyclohexyl(hydroxy)phenylacetate
Oxybutynin Hydrochloride
HEALTH CANADA PATENTS

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 4 USDMF, 2 NDC API, 8 Listed Suppliers, $ API Reference Price

12 API Suppliers
4 USDMF
2 NDC API
8 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

36 FDF Dossiers, 4 FDA Orange Book, 9 Europe, 4 Australia, 7 South Africa, 12 Listed Dossiers

36 FDF Dossiers
4 FDA Orange Book
9 Europe
4 Australia
7 South Africa
12 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM, EXTENDED RELEASE;TRANSDERMAL - 3.9MG/24HR, GEL, METERED;TRANSDERMAL - 3%, FILM, EXTENDED RELEASE;TRANSDERMAL - 3.9MG/24HR

FILM, EXTENDED RELEASE;TRANSDERMAL - 3.9MG/24HR
GEL, METERED;TRANSDERMAL - 3%
FILM, EXTENDED RELEASE;TRANSDERMAL - 3.9MG/24HR

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Actylis, 2 BASF, 1 Finar, 1 Valens Pharmachem

1 Nanjing Well Pharmaceutical
1 Actylis
2 BASF
1 Finar
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

3 Topical, 3 Film Formers & Plasticizers, 2 Solubilizers, 2 Parenteral, 1 Emulsifying Agents, 1 Thickeners and Stabilizers

3 Topical
3 Film Formers & Plasticizers
2 Solubilizers
2 Parenteral
1 Emulsifying Agents
1 Thickeners and Stabilizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 4 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
4 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 11 Finished Drug Prices

2 US Medicaid Prescriptions
11 Finished Drug Prices

MARKET PLACE

4 APIs, 1 FDF Dossiers

4 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 Health Canada Patents

1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 3 Others

2 EDQM
1 USP
3 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 653 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Gowling WLG (Canada) LLP

filter Patent Reset all filters

1 All

01 12406064

filter Product Reset all filters

1 All

01 1Oxybutynin

filter Dosage Reset all filters

1 All

01 1Transdermal Patch

filter Exp Date Reset all filters

1 All

01 12021-04-24

Product Main Page

01

Gowling WLG (Canada) LLP

2024 ISPE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2021-04-24

Date Granted : 2011-03-15

Brand Name : OXYTROL

Patent Number : 2406064

Filing Date : 2001-04-24

Strength per Unit : 36 mg

Dosage Form : Transdermal Patch

Human Or VET : Human

Route of Administration : Transdermal

Patent Expiration Date : 2021-04-24

Date Granted : 2011-03-15

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?